Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesConvaTec Group PLC

ConvaTec Group PLC

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
240.8 GBX -4.20 ( 1.71%)
Last update at 2026-10-27T16:36:00Z
VOLUME
5392172
Market Cap
4370.16M
P/E
37.27

Momentum Score

…

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
240.80
Low
245.20
High
52 Week Price Range
209.40
Low
309.42
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

ConvaTec Group PLC makes medical products and devices for wound care, ostomy care, continence and critical care, supplying hospitals and patients worldwide. Long-term growth may be supported by aging populations, rising chronic disease prevalence, recurring consumable revenue and product innovation, which could support steady cash flows.
Principal risks include pricing and reimbursement pressure, intense competition, regulatory and product-safety hurdles, foreign-exchange exposure and execution risks from supply-chain disruption or acquisitions.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
245.00
Dividend Yield
3.20%
Revenue TTM
2439.00M
Revenue Per Share
1.21
Gross Profit TTM
1372.00M
Debt / Equity
1.06
ROE
10.91%
Net Debt
1537.56M
ROCE
13.12%
Diluted EPS TTM
0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 234.83M 245.90M 167.40M 81.90M 151.30M
Net income 178.67M 190.50M 130.30M 62.90M 117.60M
Selling general administrative - 195.00M 200.40M 214.90M 285.30M
Selling and marketing expenses - 645.20M 610.90M 575.90M 539.70M
Gross profit 1374.24M 1283.60M 1204.20M 1103.90M 1123.10M
Reconciled depreciation - 220.80M 214.80M 209.20M 210.60M
Ebit 415.54M 319.40M 280.10M 207.30M 203.60M
Ebitda 644.24M 540.20M 455.50M 417.60M 405.70M
Depreciation and amortization 228.70M 220.80M 175.40M 210.30M 202.10M
Operating income 415.54M 324.90M 262.70M 207.30M 203.60M
Other operating expenses 2074.63M 1964.30M 1879.70M 1851.40M 1834.70M
Interest expense 71.47M 73.50M 73.30M 64.70M 44.30M
Tax provision - 56.00M 37.10M 19.00M 33.70M
Interest income - 4.80M 5.20M 5.50M 0.80M
Net interest income - -78.10M -75.50M -67.70M -43.50M
Income tax expense 56.15M 56.00M 37.10M 19.00M 33.70M
Total revenue 2490.17M 2289.20M 2142.40M 2072.50M 2038.30M
Total operating expenses 958.70M 958.70M 941.50M 882.80M 919.50M
Cost of revenue 1115.93M 1005.60M 938.20M 968.60M 915.20M
Total other income expense net -180.71M -79.00M -95.30M -125.40M -52.30M
Net income from continuing ops - 189.90M 130.30M 62.90M 117.60M
Net income applicable to common shares - - - 62.90M 117.60M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 3782.38M 3515.00M 3713.70M 3592.00M 3674.00M
Intangible assets 646.24M 805.90M 935.00M 924.90M 902.20M
Other current assets 10.00M 78.00M 105.80M 408.60M 338.60M
Total liab 2263.82M 1826.10M 2021.00M 1982.30M 1979.20M
Total stockholder equity 1518.55M 1688.90M 1692.70M 1609.70M 1694.80M
Deferred long term liab - - - - 1.90M
Other current liab 97.04M 301.70M 320.00M 166.20M 62.20M
Common stock 251.09M 251.50M 251.50M 250.70M 247.00M
Capital stock - 251.50M 251.50M 250.70M 247.00M
Retained earnings 1306.48M -828.40M -888.70M -892.20M -842.00M
Other liab - - - 169.00M 136.50M
Good will 1350.49M 1290.20M 1298.80M 1224.60M 1156.30M
Other assets - - - - 54.40M
Cash 75.03M 64.70M 97.60M 143.80M 463.40M
Total current liabilities 616.22M 512.30M 536.40M 533.10M 569.20M
Net debt 1537.56M 1136.90M 1214.80M 1156.40M 971.70M
Short term debt 26.01M 22.00M 20.70M 20.30M 164.50M
Short long term debt - - - 0.00M 144.80M
Short long term debt total 1612.59M 1201.60M 1312.40M 1300.20M 1435.10M
Other stockholder equity 31.01M 2265.80M 180.40M 2251.20M 2289.80M
Property plant equipment - - - 479.80M 450.30M
Total current assets 940.34M 793.30M 870.00M 889.30M 1110.80M
Net tangible assets - - - - -363.70M
Short term investments - - 0.70M - -
Net receivables 439.16M 301.00M 269.80M 364.00M 323.50M
Long term debt - 1122.80M 1226.90M 1211.90M 1199.80M
Inventory 416.15M 349.60M 396.10M 336.90M 308.80M
Accounts payable 493.18M 124.90M 136.90M 346.60M 342.50M
Accumulated other comprehensive income -70.03M - 2149.50M - -
Non currrent assets other - 15.90M 38.50M 46.80M 25.50M
Non current assets total 2842.03M 2721.70M 2843.70M 2702.70M 2563.20M
Capital lease obligations - 78.80M 85.50M 88.30M 90.50M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -160.80M -285.70M -348.30M -206.50M
Change to liabilities - - - 40.70M 10.70M
Total cashflows from investing activities -212.36M -160.80M -285.70M -348.30M -206.50M
Net borrowings - -98.00M 9.40M -149.00M -114.10M
Total cash from financing activities -263.41M -263.80M -124.00M -237.10M -199.90M
Change to operating activities - - - -3.30M 6.70M
Net income 178.67M 190.50M 130.30M 62.90M 117.60M
Change in cash -3.94M -32.90M -46.20M -319.60M -102.00M
Begin period cash flow 78.97M 97.60M 143.80M 463.40M 565.40M
End period cash flow 75.03M 64.70M 97.60M 143.80M 463.40M
Total cash from operating activities 479.86M 396.20M 367.40M 281.70M 305.90M
Depreciation 228.70M 220.80M 214.80M 209.20M 210.60M
Other cashflows from investing activities - 2.70M 0.60M - -
Dividends paid 142.94M 130.20M 110.70M 88.10M 85.80M
Change to inventory -38.80M 27.50M -49.40M -36.30M -19.60M
Change to account receivables -59.22M -26.90M 18.70M -63.60M -29.40M
Sale purchase of stock -332.84M -10.90M 0.00M - 0.00M
Other cashflows from financing activities -46.97M -24.70M -22.70M 693.50M 469.80M
Change to netincome - - - 72.10M 9.30M
Capital expenditures 137.83M 122.10M 129.20M 144.20M 94.10M
Change in working capital -33.69M 3.30M -6.10M -62.50M -31.60M
Stock based compensation - 19.80M 14.60M 16.70M 16.40M
Other non cash items 137.83M -38.20M 13.80M 55.40M 48.00M
Free cash flow 342.03M 274.10M 238.20M 137.50M 211.80M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CTEC
ConvaTec Group PLC		 -4.20
1.71%		 240.80 37.27 14.66 1.79 3.77 2.94 13.89
AMS
Advanced Medical Solutions Group plc		 1.00
0.35%		 283.00 40.60 16.84 1.92 1.66 2.16 11.16
TSTL
Tristel		 -
-%		 407.50 23.75 19.08 3.68 5.29 3.43 13.18
SPEC
Inspecs Group plc		 -3.00
3.33%		 87.00 - 16.16 0.43 0.95 0.62 7.94
BVC
Batm Advanced Communications Ltd		 -0.25
2.16%		 11.30 - 39.53 0.36 0.90 0.37 2.44

Profile*

ConvaTec Group PLC

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

20 Eastbourne Terrace, London, United Kingdom, W2 6LG

44 11 8952 8100

https://www.convatecgroup.com

10910

Name Title Year Born
Mr. Karim Bitar CEO & Director 1965
Mr. Jonathan P. Mason Group CFO & Director 1964
Mr. Donal Balfe Exec. VP and Chief of Quality & Operations NA
Dr. Divakar Ramakrishnan Ph.D. Exec. VP & Chief Technology Officer NA
Mr. Mark Reynolds Director of Investor Relations NA
Ms. Kate Postans VP of Investor Relations & Corp. Communications NA
Ms. Natalia Kozmina Exec. VP & Chief HR Officer NA
Mr. Christian Hoengaard Sr. VP & GM - USA NA
Ms. Kjersti Grimsrud Biotechnology, M.Sc. Pres & COO of Infusion Care 1961
Mr. Supratim Bose Pres & COO of Global Emerging Markets 1952

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…